Free Trial

Celestica, Inc. $CLS Shares Sold by Axiom Investors LLC DE

Celestica logo with Computer and Technology background

Key Points

  • Axiom Investors LLC DE reduced its holdings in Celestica, Inc. by 88.7%, selling 885,708 shares and owning about 112,714 shares worth $8.88 million as of the latest SEC filing.
  • Celestica's stock has recently seen positive adjustments from analysts, with Canaccord Genuity increasing its price objective from $126 to $240, indicating strong market optimism.
  • For the most recent quarter, Celestica reported an earnings per share of $1.39, exceeding expectations and demonstrating a revenue increase of 21% year-over-year, with a revenue total of $2.89 billion.
  • Looking to export and analyze Celestica data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Axiom Investors LLC DE cut its holdings in shares of Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 88.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 112,714 shares of the technology company's stock after selling 885,708 shares during the quarter. Axiom Investors LLC DE owned 0.10% of Celestica worth $8,883,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. CoreCap Advisors LLC raised its holdings in shares of Celestica by 5.4% in the 4th quarter. CoreCap Advisors LLC now owns 1,760 shares of the technology company's stock valued at $162,000 after purchasing an additional 90 shares in the last quarter. First National Bank of Hutchinson raised its stake in Celestica by 2.5% in the first quarter. First National Bank of Hutchinson now owns 4,914 shares of the technology company's stock valued at $387,000 after buying an additional 120 shares in the last quarter. Private Trust Co. NA lifted its holdings in Celestica by 14.1% during the 1st quarter. Private Trust Co. NA now owns 993 shares of the technology company's stock worth $78,000 after buying an additional 123 shares during the last quarter. Csenge Advisory Group lifted its holdings in Celestica by 7.1% during the 1st quarter. Csenge Advisory Group now owns 2,593 shares of the technology company's stock worth $218,000 after buying an additional 171 shares during the last quarter. Finally, Bay Rivers Group boosted its position in shares of Celestica by 1.1% during the 1st quarter. Bay Rivers Group now owns 19,494 shares of the technology company's stock worth $1,536,000 after acquiring an additional 215 shares in the last quarter. Institutional investors and hedge funds own 67.38% of the company's stock.

Celestica Stock Performance

NYSE CLS traded up $10.58 on Thursday, hitting $212.68. 3,127,323 shares of the company's stock were exchanged, compared to its average volume of 4,267,479. The firm's 50-day moving average price is $174.47 and its two-hundred day moving average price is $126.55. The firm has a market cap of $24.46 billion, a price-to-earnings ratio of 46.03 and a beta of 1.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.44 and a quick ratio of 0.86. Celestica, Inc. has a fifty-two week low of $40.65 and a fifty-two week high of $218.80.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last announced its quarterly earnings data on Monday, July 28th. The technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.23 by $0.16. Celestica had a net margin of 5.11% and a return on equity of 28.23%. The firm had revenue of $2.89 billion during the quarter, compared to analysts' expectations of $2.65 billion. During the same quarter last year, the business earned $0.91 earnings per share. The business's revenue for the quarter was up 21.0% compared to the same quarter last year. Celestica has set its Q3 2025 guidance at 1.370-1.530 EPS. FY 2025 guidance at 5.500-5.500 EPS. On average, research analysts expect that Celestica, Inc. will post 4.35 EPS for the current year.

Wall Street Analyst Weigh In

CLS has been the subject of several recent analyst reports. BMO Capital Markets restated an "outperform" rating and set a $130.00 target price (up previously from $118.00) on shares of Celestica in a research note on Thursday, May 22nd. Citigroup boosted their price objective on shares of Celestica from $172.00 to $212.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 30th. CICC Research began coverage on shares of Celestica in a research report on Tuesday, August 19th. They issued an "outperform" rating on the stock. Royal Bank Of Canada lifted their price target on shares of Celestica from $185.00 to $225.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Finally, UBS Group reaffirmed a "neutral" rating and set a $208.00 price objective (up previously from $101.00) on shares of Celestica in a report on Wednesday, July 30th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $168.92.

Check Out Our Latest Report on Celestica

Celestica Profile

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

See Also

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Should You Invest $1,000 in Celestica Right Now?

Before you consider Celestica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.

While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines